Stage III Bladder Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0109731 (Stage III Bladder Cancer AJCC v8)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03319745Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical CystectomyTreatment